PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
2583256-2	1989	Anecdotal reports have suggested that patients who failed IFN could achieve durable responses with dCF, although the frequency with which this was said to have occurred was unknown.	Pentostatin	99-102	interferon alpha 1	Homo sapiens	58-61	
2583256-3	1989	We reviewed the available data on the responsiveness of HCL to dCF after IFN therapy by analyzing cases reported in the literature and those treated under the Special Exception mechanism of the National Cancer Institute, Division of Cancer Treatment.	Pentostatin	63-66	interferon alpha 1	Homo sapiens	73-76	
2583256-6	1989	dCF is an active agent in HCL both as initial therapy and for the salvage of patients who have failed IFN.	Pentostatin	0-3	interferon alpha 1	Homo sapiens	102-105